» Articles » PMID: 30456443

Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis

Overview
Date 2018 Nov 21
PMID 30456443
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex encephalitis (HSE) is often caused by infection with herpes simplex virus 1 (HSV-1), a neurotropic double-stranded DNA virus. HSE infection always impacts the temporal and frontal lobes or limbic system, leading to edema, hemorrhage, and necrotic changes in the brain parenchyma. Additionally, patients often exhibit severe complications following antiviral treatment, including dementia and epilepsy. HSE is further associated with disruptions to the blood-brain barrier (BBB), which consists of microvascular endothelial cells, tight junctions, astrocytes, pericytes, and basement membranes. Following an HSV-1 infection, changes in BBB integrity and permeability can result in increased movement of viruses, immune cells, and/or cytokines into the brain parenchyma. This leads to an enhanced inflammatory response in the central nervous system and further damage to the brain. Thus, it is important to protect the BBB from pathogens to reduce brain damage from HSE. Here, we discuss HSE and the normal structure and function of the BBB. We also discuss growing evidence indicating an association between BBB breakdown and the pathogenesis of HSE, as well as future research directions and potential new therapeutic targets. Graphical Abstract During herpes simplex encephalitis, the functions and structures of each composition of BBB have been altered by different factors, thus the permeability and integrity of BBB have been broken. The review aim to explore the potential mechanisms and factors in the process, probe the next research targets and new therapeutic targets.

Citing Articles

Clinical and pathological risk factors for postencephalitic epilepsy after herpes simplex virus-1 encephalitis in children.

Yin P, Tian P, Zhang X, Zhang D, Yang X, Yang L Sci Rep. 2025; 15(1):6471.

PMID: 39987356 PMC: 11846938. DOI: 10.1038/s41598-025-91438-6.


Alzheimer's disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles.

Hosseininasab S, Ebrahimi R, Yaghoobpoor S, Kazemi K, Khakpour Y, Hajibeygi R Front Neurosci. 2025; 18():1513095.

PMID: 39840010 PMC: 11747386. DOI: 10.3389/fnins.2024.1513095.


Novel Perspectives Focused on the Relationship Between Herpesvirus Encephalitis and Anti-GFAP-Antibody-Positive Astrocytopathy.

Liao Y, Wen L, Zheng R, Shen Y, Ha T, Lin M Mol Neurobiol. 2024; .

PMID: 39731639 DOI: 10.1007/s12035-024-04660-0.


Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer's Disease: Possible Mechanisms and Therapeutic Implications.

Chauhan P, Begum M, Narapureddy B, Gupta S, Wadhwa K, Singh G Mol Neurobiol. 2024; .

PMID: 39648189 DOI: 10.1007/s12035-024-04535-4.


Genetic defects of brain immunity in childhood herpes simplex encephalitis.

Zhang S, Casanova J Nature. 2024; 635(8039):563-573.

PMID: 39567785 PMC: 11822754. DOI: 10.1038/s41586-024-08119-z.


References
1.
Meyding-Lamade U, Lamade W, Wildemann B, Sartor K, Hacke W . Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery. Clin Infect Dis. 1999; 28(1):148-9. DOI: 10.1086/517183. View

2.
Adamson P, Etienne S, Couraud P, Calder V, Greenwood J . Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol. 1999; 162(5):2964-73. View

3.
Fujii S, Akaike T, Maeda H . Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology. 1999; 256(2):203-12. DOI: 10.1006/viro.1999.9610. View

4.
Read S, Kurtz J . Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol. 1999; 37(5):1352-5. PMC: 84773. DOI: 10.1128/JCM.37.5.1352-1355.1999. View

5.
Mantovani A . The chemokine system: redundancy for robust outputs. Immunol Today. 1999; 20(6):254-7. DOI: 10.1016/s0167-5699(99)01469-3. View